✦ LIBER ✦

1.12.2 ADVANCES IN CSF BIOMARKERS OF PARKINSON'S DISEASE

✍ Scribed by P. LeWitt

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recent advances in CSF biomarkers for Pa

✍ Peter LeWitt 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 109 KB

CSF biomarkers in different phenotypes o

✍ Kurt A. Jellinger 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 144 KB

2.131 CSF CLUSTERIN IS ASSOCIATED WITH C

✍ K.D. van Dijk; W. Jongbloed; C.E. Teunissen; T. Koene; H.J. Groenewegen; H.W. Be 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

CSF xanthine, homovanillic acid, and the

✍ Peter LeWitt; Lonni Schultz; Peggy Auinger; Mei Lu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 464 KB

6 Dopamine CSF metabolites as reliable s

✍ E. Olivola; G. Angeleri; M. Stampanoni; M. Pierantozzi; A. Pisani; A. Stefani 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 45 KB

Biomarkers in Parkinson’s Disease

✍ John C. Morgan; Shyamal H. Mehta; Kapil D. Sethi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 170 KB